Advisornet Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.3K | Sell |
6
-8
| -57% | -$1.53K | ﹤0.01% | 1988 |
|
|
2026
Q1 | $2.57K | Buy |
14
+5
| +56% | +$921 | ﹤0.01% | 1871 |
|
|
2025
Q4 | $1.58K | Hold |
9
| – | – | ﹤0.01% | 1934 |
|
|
2025
Q3 | $1.26K | Hold |
9
| – | – | ﹤0.01% | 1933 |
|
|
2025
Q2 | $1.13K | Sell |
9
-6
| -40% | -$748 | ﹤0.01% | 1928 |
|
|
2025
Q1 | $2.05K | Sell |
15
-47
| -76% | -$6.72K | ﹤0.01% | 1785 |
|
|
2024
Q4 | $9.48K | Sell |
62
-14
| -18% | -$2.36K | ﹤0.01% | 1339 |
|
|
2024
Q3 | $14.7K | Buy |
76
+36
| +90% | +$7.53K | ﹤0.01% | 1311 |
|
|
2024
Q2 | $9.27K | Buy |
40
+16
| +67% | +$3.48K | ﹤0.01% | 1336 |
|
|
2024
Q1 | $5.17K | Sell |
24
-26
| -52% | -$6.09K | ﹤0.01% | 1431 |
|
|
2023
Q4 | $12.9K | Sell |
50
-59
| -54% | -$14.5K | ﹤0.01% | 1235 |
|
|
2023
Q3 | $28K | Sell |
109
-419
| -79% | -$112K | ﹤0.01% | 940 |
|
|
2023
Q2 | $150K | Sell |
528
-5
| -0.9% | -$1.49K | 0.01% | 534 |
|
|
2023
Q1 | $148K | Buy |
533
+59
| +12% | +$16.3K | 0.01% | 527 |
|
|
2022
Q4 | $131K | Sell |
474
-67
| -12% | -$18.9K | 0.01% | 563 |
|
|
2022
Q3 | $144K | Sell |
541
-99
| -15% | -$21K | 0.01% | 572 |
|
|
2022
Q2 | $131K | Buy |
640
+4
| +0.6% | +$818 | 0.01% | 599 |
|
|
2022
Q1 | $134K | Sell |
636
-92
| -13% | -$20K | 0.01% | 659 |
|
|
2021
Q4 | $175K | Sell |
728
-104
| -13% | -$26.7K | 0.01% | 635 |
|
|
2021
Q3 | $235K | Buy |
832
+22
| +3% | +$7.21K | 0.02% | 537 |
|
|
2021
Q2 | $280K | Sell |
810
-218
| -21% | -$66K | 0.02% | 512 |
|
|
2021
Q1 | $288K | Buy |
1,028
+400
| +64% | +$108K | 0.02% | 463 |
|
|
2020
Q4 | $154K | Sell |
628
-300
| -32% | -$77.4K | 0.01% | 570 |
|
|
2020
Q3 | $263K | Buy |
928
+100
| +12% | +$27.9K | 0.02% | 439 |
|
|
2020
Q2 | $222K | Buy |
828
+320
| +63% | +$96.2K | 0.02% | 475 |
|
|
2020
Q1 | $161K | Sell |
508
-170
| -25% | -$51.6K | 0.01% | 507 |
|
|
2019
Q4 | $201K | Hold |
678
| – | – | 0.02% | 503 |
|
|
2019
Q3 | $158K | Buy |
678
+263
| +63% | +$61.2K | 0.01% | 556 |
|
|
2019
Q2 | $97K | Sell |
415
-58
| -12% | -$13.4K | 0.01% | 619 |
|
|
2019
Q1 | $112K | Buy |
473
+250
| +112% | +$78.7K | 0.01% | 529 |
|
|
2018
Q4 | $67K | Buy |
223
+73
| +49% | +$23.3K | 0.01% | 613 |
|
|
2018
Q3 | $53K | Sell |
150
-9
| -6% | -$3.1K | 0.01% | 701 |
|
|
2018
Q2 | $46K | Buy |
159
+21
| +15% | +$5.9K | 0.01% | 727 |
|
|
2018
Q1 | $38K | Sell |
138
-295
| -68% | -$91.6K | 0.01% | 761 |
|
|
2017
Q4 | $138K | Buy |
+433
| New | +$139K | 0.02% | 418 |
|
Other funds holding BIIB
Advisornet Financial's BIIB Position: Q2 2026 in Review
Advisornet Financial reduced its Biogen (BIIB) stake by 57% in Q2 2026, selling an estimated $1.53K and leaving 6 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.
Advisornet Financial first reported a position in BIIB in Q4 2017 and has held it in 35 quarters since. The position peaked at $288K in Q1 2021. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Advisornet Financial held 6 shares of Biogen worth $1.3K as of Q2 2026.
- Advisornet Financial sold 8 Biogen shares in Q2 2026, an estimated $1.53K.
- Biogen made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1988 holding.
- Advisornet Financial first reported a position in Biogen in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's Biogen position peaked at $288K in Q1 2021.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.